DECISION stands for "DEcompensated CIrrhoSIs: identification of new cOmbiNatorial therapies based on systems approaches". It is a large-scale, collaborative research project that intends to reduce the number of patients that die of acute-on-chronic liver failure (ACLF), in other words, cirrhosis in its end-state. 21 institutions from 10 European countries participate in this Horizon2020-funded, 5.5-year-long undertaking which is spearheaded by Prof. Pierre-Emmanuel Rautou at EFCLIF in Barcelona, Spain.
Company Details
- Address
- Efclif - Travessera De Gràcia, 11, 7th Floor,spain
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://decision-for-liver.eu
- Keywords
- Decompensated cirrhosis: Identification of new combinatorial therapies based on systems approaches.
- HQ
- Barcelona
- Competitors
- European Liver Patients' Association - ELPA, MICROB-PREDICT, Nastavni zavod za Hitnu medicinu grada Zagreba, Fatty Liver Alliance, Liveration, European Foundation for the Study of Chronic Liver Failure (EF CLIF), A-TANGO, REPO-TRIAL, concentris research management GmbH, Legenes hus kurs- og konferansesenter, Oslo.
Decision-Project Questions
Decision-Project's website is https://decision-for-liver.eu
Decision-Project's LinkedIn profile is https://es.linkedin.com/company/decision-project
Decision-Project's industry is
Research Services
Decision-Project's top competitors are
European Liver Patients' Association - Elpa,
Microb-Predict,
Nastavni Zavod Za Hitnu Medicinu Grada Zagreba,
Fatty Liver Alliance,
Liveration,
European Foundation For The Study Of Chronic Liver Failure (Ef Clif),
A-Tango,
Repo-Trial,
Concentris Research Management Gmbh,
Legenes Hus Kurs- Og Konferansesenter, Oslo.
Decision-Project's categories are Research Services
